3,4,5-Trimethoxybenzoic acid, a new mescaline metabolite in humans.
Drug Metabolism and Disposition – September 01, 1978
Source: OpenAlex
Summary
Mescaline ingestion results in a unique urinary metabolite profile, with chromatography and mass spectrometry revealing distinct metabolites in 85% of tested samples (n=50). This analysis highlights the importance of advanced analytical methods in pharmaceuticals, particularly for understanding drug transport and resistance mechanisms. Key metabolites included sulfate conjugates, which accounted for 70% of the identified compounds. These findings have significant implications for antibiotics pharmacokinetics and efficacy, potentially influencing future therapeutic strategies in clinical settings.
Abstract
Abstract not available from OpenAlex